Skip to main content

Spirecut establishes presence in the Basel Area

| News

Spirecut establishes presence in the Basel Area

04.04.2023

Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. The company is now operating out of “The 5th Floor” co-working space in Muttenz. The startup has relocated with the help of the “100 fürs Baselbiet” program operated by BLKB and with the support of Basel Area Business & Innovation.

Frédéric Schuind, CEO and founder of Spirecut (img: Spirecut)

Spirecut AG is now based in Muttenz in the canton of Basel-Landschaft. The medtech startup, which was headquartered in Fribourg up until the end of March, develops and sells instruments for two surgical fields of hand operations: carpal tunnel syndrome and trigger finger. In each case, the instruments facilitate minimally invasive procedures in which no incision is necessary. Rather, the surgeon merely has to puncture the skin.

As a result, in contrast to conventional operations, patients can immediately use their hand as normal again. Spirecut was awarded third place in the 2022 Swiss Innovation Challenge.

Founded in 2020, the company was supported in establishing its presence in the Basel Area by the “100 fürs Baselbiet” promotional program operated by BLKB, the cantonal bank for the canton of Basel-Landschaft, further details of which can be found in a statement. The aim of the initiative is to bring 100 companies to the canton of Basel-Landschaft, with debt capital of up to 500,000 Swiss francs available to finance the next growth step. The bank also offers coaching and mentoring in all relevant areas via its partners.

Unique ecosystem for medtech firms

The investment and innovation promotion agency Basel Area Business & Innovation functioned as a relocation partner and aided the search for suitable premises, which were eventually found at The 5th Floor coworking space in Muttenz. In the words of the Swiss-Belgian founder and CEO of Spirecut, Professor Frédéric Schuind, his company opted for the Basel region due to the fact that “it offers a unique ecosystem for medtech firms that encourages innovation and collaboration in a supportive environment”.

The medtech firm is keen to get in touch with the leading players in the Basel Area to sound out cooperation opportunities, informs Spirecut. The proximity to the University of Applied Sciences and Arts Northwestern Switzerland (FHNW), as well as the University of BaselUniversity Hospital Basel and the Basel Area life sciences ecosystem and its suppliers, will open up recruitment opportunities for the company.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More